Over the past 12 months, $VRTX has been mentioned 14 times by 4 distinct FinTwit voices, with biotech-focused commentary dominating the discussion. Adam Feuerstein (@adamfeuerstein) accounts for 11 of these mentions, making him by far the most active voice discussing the stock. The ticker first appeared in the archive on August 4, 2025, and most recent mentions came in early July 2026. The most-discussed development involved $VRTX acquiring $CRNX for a $10 billion deal, with Feuerstein noting that Crinetics had been significantly underperforming the $XBI index prior to the acquisition.